BioSpace News Archive

Drug Development

Suven Life Sciences Ltd’s Alzheimer Drug Candidate SUVN-502 Successfully Completed All Chronic Toxicological (tox) Studies and Demonstrated Very High Margin of Safety (MOS)

May 18, 2011
·
1 min read
DNA Genotek Expands Product Portfolio with Introduction of Omnigene(TM) DISCOVER for Infectious Disease Sampling

May 18, 2011
·
3 min read
Business

Genesis Biopharma, Inc. Forms Scientific and Medical Advisory Board

May 18, 2011
·
2 min read
Drug Development

Glycotope Enrolls First Patients in Phase I Trial for FSH-GEX(TM)

May 18, 2011
·
2 min read
BioMidwest

Half of Prostate Cancers Could Potentially Benefit from New Type of Cancer Drugs, University of Michigan Study Finds

May 18, 2011
·
3 min read
Drug Development

Roche Data Highly Anticipated at American Society of Clinical Oncology; Rumored to Present Positive Progress in Skin, Lung, and Ovarian Cancer Drugs

May 18, 2011
·
1 min read
Deals

Is Takeda Pharmaceutical Co. Ltd. Finally Set to Buy Nycomed for $12 Billion? - Deal to be Formally Announced Today

May 18, 2011
·
1 min read
Drug Development

Allon Therapeutics, Inc. Updates Progress of Pivotal Phase 2/3 Clinical Trial

May 18, 2011
·
5 min read
Deals

BioLineRx Ltd. Acquires Exclusive License Rights From Algen for Cancer Therapeutic BL-7030

May 18, 2011
·
1 min read
BioCapital

Syngene Release: Major Ophthalmology Center Studies Proteomic Profiles of Ocular Diseases

May 18, 2011
·
1 min read